Prab: CSV import

2024-12-09T15:21:18Z

CSV import

← Older revision		Revision as of 15:21, 9 December 2024
Line 1:		Line 1:
	{{Infobox company		[[File:Lonza.svg\|thumb]] [[File:Lonza Logo.svg\|thumb]] [[File:Lonza Logo.svg\|thumb]] {{Infobox company
	\| name = Lonza Group		\| name = Lonza Group
	\| logo = ~~Lonza logo~~.svg		\| logo = Lonza_Logo.svg
	\| type = Public		\| type = Public
	\| traded_as = SIX: LONN		\| traded_as = SIX: LONN
	\| industry = Pharmaceuticals, Biotechnology		\| industry = Pharmaceuticals, Biotechnology
	\| founded = 1897		\| founded = 1897
	\| founder = Alexander von ~~Hubner~~		\| founder = Alexander von Hubel
	\| headquarters = Basel, Switzerland		\| headquarters = Basel, Switzerland
	\| key_people = Pierre-Alain Ruffieux (CEO)		\| key_people = Pierre-Alain Ruffieux (CEO)
Line 15:		Line 15:
	}}		}}

	'''Lonza Group''' is a leading global provider of integrated healthcare solutions, specializing in the development, manufacturing, and ~~supply~~ of ~~active~~ pharmaceutical ~~ingredients (APIs), biopharmaceuticals,~~ and ~~specialty chemicals~~. Founded in 1897 in the Swiss Alps, Lonza has grown to become a key player in the ~~pharmaceutical and biotechnology industries~~, with a ~~strong~~ focus on innovation and sustainability.		'''Lonza Group''' is a leading global provider of integrated healthcare solutions, specializing in the development, manufacturing, and commercialization of pharmaceutical and biotechnology products. Founded in 1897 in the Swiss Alps, Lonza has grown to become a key player in the life sciences industry, with a focus on innovation and sustainability.

	==History==		==History==
	Lonza was established in 1897 in the small Swiss town of Gampel, initially focusing on the production of electricity and calcium carbide. Over the years, the company expanded its operations and ~~diversified its product offerings~~. In the ~~mid-20th century~~, Lonza shifted its focus towards ~~the chemical and pharmaceutical sectors~~, ~~establishing itself as~~ a ~~leader in the production~~ of ~~fine chemicals and active pharmaceutical ingredients~~.		Lonza was established in 1897 in the small Swiss town of Gampel, initially focusing on the production of electricity and calcium carbide. Over the years, the company expanded its operations into the chemical and pharmaceutical sectors. In the 1970s, Lonza shifted its focus towards biotechnology, which has since become a core component of its business strategy.

	In the ~~21st century~~, Lonza has ~~continued to grow through~~ strategic acquisitions ~~and partnerships, enhancing~~ its capabilities in ~~biopharmaceutical manufacturing and cell and gene therapy. The company is now headquartered~~ in ~~Basel~~, ~~Switzerland, and operates globally with facilities~~ in ~~Europe, North America, and Asia~~.		In 1999, Lonza was spun off from Alusuisse-Lonza Group Ltd and became an independent company listed on the Swiss Stock Exchange. Since then, Lonza has made several strategic acquisitions to enhance its capabilities in the life sciences sector, including the acquisition of Capsugel in 2017, a leader in capsule-based drug delivery solutions.

	==Operations==		==Operations==
	Lonza operates through ~~several business~~ segments:		Lonza operates through two main segments: Pharma & Biotech and Specialty Ingredients.

	* '''Pharma & Biotech~~''': This~~ segment focuses on the development and ~~manufacturing~~ of APIs, biopharmaceuticals, and cell and gene therapies. Lonza provides end-to-end solutions for ~~pharmaceutical companies~~, from early-stage development to commercial manufacturing.		===Pharma & Biotech===
			The Pharma & Biotech segment focuses on the development and manufacture of active pharmaceutical ingredients (APIs), biopharmaceuticals, and cell and gene therapies. Lonza provides end-to-end solutions for its clients, from early-stage development to commercial manufacturing. The company is known for its expertise in mammalian cell culture, microbial fermentation, and chemical synthesis.

	* '''Specialty Ingredients~~''': This~~ segment offers a wide range of ~~specialty chemicals used in various industries~~, including ~~agrochemicals~~, ~~coatings~~, and ~~personal care products~~.		===Specialty Ingredients===
			The Specialty Ingredients segment offers a wide range of products, including microbial control solutions, personal care ingredients, and nutritional supplements. Lonza's microbial control solutions are used in various industries, such as water treatment, paints and coatings, and wood protection.
	* '~~''Capsules & Health Ingredients''': Lonza is a leading supplier of capsules~~ and ~~health ingredients~~, ~~providing innovative solutions for the nutraceutical~~ and ~~pharmaceutical markets~~.

	==Research and Development==		==Research and Development==
	Lonza invests significantly in research and development to drive innovation and maintain its competitive edge. The company collaborates with academic institutions, research organizations, and industry partners to advance its ~~technologies~~ and develop new products. ~~Key~~ areas ~~of focus include bioprocessing~~, cell and gene therapy, and sustainable chemistry.		Lonza invests significantly in research and development to drive innovation and maintain its competitive edge. The company collaborates with academic institutions, research organizations, and industry partners to advance its technological capabilities and develop new products. Lonza's R&D efforts are focused on areas such as biologics, cell and gene therapy, and sustainable chemistry.

	==Sustainability==		==Sustainability==
	Lonza is committed to sustainability and ~~responsible business practices. The company~~ has implemented various initiatives to reduce its environmental impact, ~~including~~ energy ~~efficiency programs, waste reduction strategies~~, and ~~sustainable sourcing~~ of ~~raw materials~~. Lonza also focuses on ~~social responsibility, supporting community development~~ and ~~promoting diversity and inclusion within its workforce~~.		Lonza is committed to sustainability and has implemented various initiatives to reduce its environmental impact. The company aims to minimize waste, reduce energy consumption, and promote the use of renewable resources. Lonza also focuses on sustainable sourcing and ethical business practices.

	==Also see==		==Also see==
			* [[Biotechnology]]
	* [[Pharmaceutical industry]]		* [[Pharmaceutical industry]]
	* [[Biotechnology]]
	* [[Active pharmaceutical ingredient]]		* [[Active pharmaceutical ingredient]]
	* [[Biopharmaceutical]]		* [[Biopharmaceutical]]
	* [[Cell therapy]]		* [[Cell therapy]]
	* [[Gene therapy]]		* [[Gene therapy]]

	~~==References==~~
	~~<references />~~

	{{Pharmaceutical companies}}		{{Pharmaceutical companies}}

Prab: CSV import

2024-12-04T18:42:21Z

CSV import

New page

{{Infobox company
| name = Lonza Group
| logo = Lonza logo.svg
| type = Public
| traded_as = SIX: LONN
| industry = Pharmaceuticals, Biotechnology
| founded = 1897
| founder = Alexander von Hubner
| headquarters = Basel, Switzerland
| key_people = Pierre-Alain Ruffieux (CEO)
| products = Active pharmaceutical ingredients, Biopharmaceuticals, Specialty chemicals
| revenue = CHF 4.5 billion (2020)
| num_employees = 15,000 (2020)
| website = [https://www.lonza.com www.lonza.com]
}}

'''Lonza Group''' is a leading global provider of integrated healthcare solutions, specializing in the development, manufacturing, and supply of active pharmaceutical ingredients (APIs), biopharmaceuticals, and specialty chemicals. Founded in 1897 in the Swiss Alps, Lonza has grown to become a key player in the pharmaceutical and biotechnology industries, with a strong focus on innovation and sustainability.

==History==
Lonza was established in 1897 in the small Swiss town of Gampel, initially focusing on the production of electricity and calcium carbide. Over the years, the company expanded its operations and diversified its product offerings. In the mid-20th century, Lonza shifted its focus towards the chemical and pharmaceutical sectors, establishing itself as a leader in the production of fine chemicals and active pharmaceutical ingredients.

In the 21st century, Lonza has continued to grow through strategic acquisitions and partnerships, enhancing its capabilities in biopharmaceutical manufacturing and cell and gene therapy. The company is now headquartered in Basel, Switzerland, and operates globally with facilities in Europe, North America, and Asia.

==Operations==
Lonza operates through several business segments:

* '''Pharma & Biotech''': This segment focuses on the development and manufacturing of APIs, biopharmaceuticals, and cell and gene therapies. Lonza provides end-to-end solutions for pharmaceutical companies, from early-stage development to commercial manufacturing.

* '''Specialty Ingredients''': This segment offers a wide range of specialty chemicals used in various industries, including agrochemicals, coatings, and personal care products.

* '''Capsules & Health Ingredients''': Lonza is a leading supplier of capsules and health ingredients, providing innovative solutions for the nutraceutical and pharmaceutical markets.

==Research and Development==
Lonza invests significantly in research and development to drive innovation and maintain its competitive edge. The company collaborates with academic institutions, research organizations, and industry partners to advance its technologies and develop new products. Key areas of focus include bioprocessing, cell and gene therapy, and sustainable chemistry.

==Sustainability==
Lonza is committed to sustainability and responsible business practices. The company has implemented various initiatives to reduce its environmental impact, including energy efficiency programs, waste reduction strategies, and sustainable sourcing of raw materials. Lonza also focuses on social responsibility, supporting community development and promoting diversity and inclusion within its workforce.

==Also see==
* [[Pharmaceutical industry]]
* [[Biotechnology]]
* [[Active pharmaceutical ingredient]]
* [[Biopharmaceutical]]
* [[Cell therapy]]
* [[Gene therapy]]

==References==
<references />

{{Pharmaceutical companies}}
{{Biotechnology companies}}

[[Category:Pharmaceutical companies of Switzerland]]
[[Category:Biotechnology companies]]
[[Category:Companies established in 1897]]
[[Category:Companies listed on the SIX Swiss Exchange]]

Lonza Group - Revision history

Prab: CSV import

Prab: CSV import